Introduction: Several large, randomized, prospective clinical trials have demonstrated that
medical therapy to reduce intraocular pressure (IOP) delays the onset and decreases …

Fixed combinations of medications that lower intraocular pressure (IOP) are increasingly
used in the treatment of glaucoma and ocular hypertension and offer several potential …

Importance While medication efficacy is well documented in clinical trials, less is known of
medication effectiveness in real-world clinical settings. Objective To assess the effectiveness …

Prescribing medical therapy for the treatment of glaucoma can be a complex process since
many parameters should be taken into consideration regarding its achievements and limits …

Intraocular pressure (IOP) reduction is currently the only therapeutic approach demonstrated
to preserve visual function in patients with glaucoma. The first line of glaucoma treatment …

Glaucoma is a leading cause of irreversible visual loss. This potentially blinding disease is a
progressive optic neuropathy associated with elevated intraocular pressure (IOP). Initial …

Aim: To evaluate the efficacy of the fixed combination ocular hypotensive therapies
compared with their non-fixed components used concomitantly for lowering intraocular …

In the last decade, numerous novel ocular hypotensive agents have been introduced for the
control of intraocular pressure (IOP). Clinicians now have more options than ever in the …

Introduction: Glaucoma is the second leading cause of blindness in the world and current
pharmacotherapies for glaucoma have remained relatively unchanged (with the exception of …

OBJECTIVE: To estimate the intraocular pressure (IOP) reduction achieved by the most
frequently prescribed glaucoma drugs and a placebo in a meta-analysis of randomized …